The physician-dispensed skincare brand, which focuses on long-term skin health and medical-grade skincare for everyday use, has announced the appointment of Marco Ficarelli as its new Chief Global Growth Officer, effective June 22, 2026.
Ficarelli joins Revision Skincare with extensive experience in global commercial leadership, international market expansion, and omnichannel business development. He will lead efforts to scale global operations, expand digital commerce internationally, and develop market-specific business models tailored to local growth opportunities.
Ficarelli began his career at Deloitte before joining Unilever and Ferrero, and has held senior executive roles at Orveon Global, Coty, Revlon, Elizabeth Arden, and Luxottica. Throughout his career, he has led businesses across Europe, Latin America, the Middle East, and Asia-Pacific, managing complex portfolios, strengthening distribution networks, and delivering consistent, profitable growth.
"Marco’s global experience and track record in scaling growth across international markets will be instrumental as we expand our footprint worldwide," said Lisa Paley, CEO of Revision Skincare. "His leadership strengthens our ability to grow strategically across both professional and consumer channels."
Accelerating global expansion in longevity skincare
Revision Skincare continues to expand its footprint within the global aesthetics and professional skincare market. The company’s growth strategy focuses on international expansion, digital commerce acceleration, and strengthening professional partnerships, while maintaining its leadership in physician-dispensed skincare.
Revision Skincare is addressing critical factors in skin aging, including barrier function, oxidative stress, and overall skin quality over time, supporting both in-office procedures and daily skincare routines worldwide.
